1.00Open1.00Pre Close0 Volume28 Open Interest7.50Strike Price0.00Turnover111.98%IV-1.51%PremiumOct 18, 2024Expiry Date1.13Intrinsic Value100Multiplier13DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.7806Delta0.1610Gamma6.16Leverage Ratio-0.0215Theta0.0019Rho4.81Eff Leverage0.0048Vega
EyePoint Pharmaceuticals Stock Discussion
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals (EYPT.US)$
$EyePoint Pharmaceuticals (EYPT.US)$
$Adverum Biotechnologies (ADVM.US)$
$Regenxbio (RGNX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Kodiak Sciences (KOD.US)$
📊⚡️📊
No comment yet